Know Cancer

or
forgot password

Prospective Study of Predictive Value of Dynamic Contrast Enhancement Magnetic Resonance Imaging With Gadolinium on the Response of a Cerebral Tumor to a Treatment With Gamma Knife


N/A
18 Years
N/A
Open (Enrolling)
Both
Cerebral Metastases

Thank you

Trial Information

Prospective Study of Predictive Value of Dynamic Contrast Enhancement Magnetic Resonance Imaging With Gadolinium on the Response of a Cerebral Tumor to a Treatment With Gamma Knife


Inclusion Criteria:



- Patient with intracerebral lesion benign or malignant wich are not concerned by the
exclusion criteria

Exclusion Criteria:

- Pancranial radiotherapy

- Residual postop lesion

- Gliomas

- Patients < 18 years old

- Anterior allergic reaction to gadolinium

- Claustrophobia.

Type of Study:

Observational

Study Design:

Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal, Time Perspective: Prospective

Principal Investigator

Jean Chenard, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Sherbrooke

Authority:

Canada: Health Canada

Study ID:

05-063

NCT ID:

NCT00156585

Start Date:

August 2005

Completion Date:

June 2006

Related Keywords:

  • Cerebral Metastases
  • cerebral metastases
  • dynamic contrast enhanced magnetic resonance imaging
  • DCE-MRI
  • gamma knife
  • Neoplasm Metastasis

Name

Location